Upstream Bio, Inc. - UPB

SEC FilingsOur UPB Tweets

About Gravity Analytica

Recent News

  • 09.15.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
  • 09.15.2025 - Stifel 2025 Virtual Immunology and Inflammation Forum
  • 09.09.2025 - Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
  • 09.09.2025 - Upstream Bio to Participate in the Stifel 2025 Virtual Immunology and Inflammation Forum
  • 09.02.2025 - Phase 2 VIBRANT Top-line Results in CRSwNP
  • 09.02.2025 - Phase 2 VIBRANT Top-line Results in CRSwNP
  • 09.02.2025 - Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
  • 09.02.2025 - Upstream Bio Reports Positive Top-Line Results from the Phase 2 VIBRANT Trial of Verekitug for the Treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
  • 09.01.2025 - Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
  • 09.01.2025 - Upstream Bio to Host Conference Call and Webcast to Report Top-Line Data from the Phase 2 VIBRANT Trial of Verekitug in Patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Recent Filings

  • 09.02.2025 - EX-99.1 EX-99.1
  • 09.02.2025 - 8-K Current report
  • 08.06.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.06.2025 - 8-K Current report
  • 08.06.2025 - EX-99.1 EX-99.1
  • 08.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors